Related Experiment Video
Updated: Apr 15, 2026

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
Cardiology: What You May Have Missed in 2025
Marina Atalla1, Vijay Gupta1, Maham Khalid1
1McMaster University, Hamilton, Ontario, Canada (M.A., V.G., M.K.).
Insights
New data in 2025 offers insights into managing common cardiovascular conditions, including hypertension, heart failure, and atrial fibrillation. Recent findings suggest coffee consumption may be safer for atrial fibrillation patients than previously thought.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Internal medicine specialists manage common cardiovascular conditions.
- Therapeutic landscapes for hypertension, heart failure, and atrial fibrillation anticoagulation are evolving.
- Acute cardiovascular disease management requires collaboration between specialists and generalists.
Purpose of the Study:
- To review recent data and evolving therapies for common cardiovascular conditions.
- To inform internal medicine specialists and subspecialists about critical updates in cardiovascular medicine.
- To provide guidance on diagnostic and therapeutic strategies for various cardiovascular diseases.
Main Methods:
- Review of recent publications and emerging data from 2025.
- Synthesis of information on therapeutic changes and clinical management strategies.
- Inclusion of studies on both common and specialized cardiovascular conditions.
Main Results:
- Updated recommendations for hypertension, heart failure, and atrial fibrillation anticoagulation.
- Guidance on imaging for coronary artery disease, beta-blocker use post-myocardial infarction, and management of older patients post-myocardial infarction.
- Highlighting novel therapies for obstructive hypertrophic cardiomyopathy and hyperlipidemia.
Conclusions:
- Generalists need to be aware of new, groundbreaking therapies.
- Recent evidence suggests coffee consumption may be safe for patients with atrial fibrillation.
- The review provides a comprehensive update for managing cardiovascular diseases in internal medicine.
Abstract:
During 2025, new data emerged that are important to internal medicine specialists and subspecialists who frequently encounter and manage patients with common cardiovascular conditions. Among these conditions, the landscape of therapy is changing with regard to hypertension, heart failure, and anticoagulation in atrial fibrillation. Management of acute cardiovascular diseases often involves collaboration between specialists and generalists. The choice of initial imaging modality in patients with suspected coronary artery disease, whether β-blockers are routinely indicated after myocardial infarction, and the role of invasive versus conservative management in older patients after myocardial infarction are all addressed in this article. Also reviewed are articles highlighting groundbreaking therapies in more specialized areas, such as obstructive hypertrophic cardiomyopathy and advanced treatment of hyperlipidemia. As these newer therapies become more widely disseminated, generalists will need to know about them. Finally, regarding a topic of perennial interest to many physicians and patients, an article addresses coffee drinking in patients with atrial fibrillation and suggests that it might be safer than previously believed.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Introduction Cardiac Emergencies
Cardiomyopathy I: Introduction and Classification
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease I: Introduction

